指南与共识心脑血管急症

COVID-19疫情期间急性心肌梗死管理:SCAI、ACC与ACEP立场声明

Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).
指南 / 共识 · J Am Coll Cardiol · 2020-04-21
一句话结论COVID-19疫情期间,具备PCI能力的医院应及时行直接PCI治疗STEMI,同时使用防护装备和专用导管室;不具备PCI能力或无法及时行直接PCI时可考虑纤溶策略。

本文是SCAI、ACC与ACEP联合发布的立场声明,针对COVID-19疫情期间急性心肌梗死(AMI)患者的系统化诊疗提出推荐。声明指出COVID-19心血管表现复杂,包括AMI、模拟STEMI表现的心肌炎、应激性心肌病、非缺血性心肌病、冠状动脉痉挛或非特异性心肌损伤,且美国人群COVID-19患病率未知、存在无症状传播风险。声明聚焦四个方面:多样临床表现、医务人员个人防护装备(PPE)、急诊科与急救医疗系统及心导管室的作用、区域STEMI救治系统。声明强调疫情期间直接PCI仍为具备PCI能力医院STEMI患者的标准治疗,需由配备PPE的专家团队在专用导管室及时实施;不具备PCI能力的转诊医院或无法执行直接PCI等特定情况可考虑纤溶策略。

要点

  • 疫情期间直接PCI仍是具备PCI能力医院STEMI患者的标准治疗,前提是能由配备PPE的专家团队在专用导管室及时实施。
  • 不具备PCI能力的转诊医院,或直接PCI无法执行或不被认为是最佳选择的特定情况,可考虑基于纤溶的策略。
  • COVID-19患者心血管表现复杂,可表现为AMI、模拟STEMI的心肌炎、应激性心肌病、非缺血性心肌病、冠状动脉痉挛或非特异性心肌损伤。
  • 美国人群COVID-19患病率未知且存在无症状传播风险,为制定AMI救治推荐带来挑战。
  • 声明聚焦四方面:多样临床表现、医务人员PPE、急诊科与急救医疗系统及心导管室的作用、区域STEMI救治系统。

适用人群与场景

  • 需要因缺血性心脏病接受心血管诊治的患者,多数可能并未感染新型冠状病毒。

处置流程与药物剂量

  • 在具备PCI能力的医院,对STEMI患者应及时行直接PCI,由配备PPE的专家团队在专用导管室实施。
  • 在不具备PCI能力的转诊医院,或直接PCI无法执行或不被认为是最佳选择的特定情况,可考虑基于纤溶的策略。

研究设计与关键结果

  • 本文为SCAI、ACC与ACEP联合发布的立场声明,针对COVID-19疫情期间AMI患者的系统化诊疗提出推荐。
  • 声明指出COVID-19心血管表现复杂,包括AMI、模拟STEMI表现的心肌炎、应激性心肌病、非缺血性心肌病、冠状动脉痉挛或非特异性心肌损伤。
  • 声明指出美国人群COVID-19患病率未知,且存在无症状传播风险。
  • 声明聚焦四方面:多样临床表现、医务人员PPE、急诊科与急救医疗系统及心导管室的作用、区域STEMI救治系统。

证据类型、等级与局限

  • 证据类型:SCAI、ACC与ACEP联合发布的立场声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 疫情期间,具备PCI能力医院对STEMI患者仍应及时行直接PCI,并由配备PPE的专家团队在专用导管室实施。
  • 不具备PCI能力的转诊医院,或直接PCI无法执行或不被认为是最佳选择的特定情况,可考虑基于纤溶的策略。

指南或共识出处

  • Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with this novel coronavirus. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating an ST-elevation myocardial infarction (STEMI) presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury, and the prevalence of COVID-19 disease in the U.S. population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

参考来源

  1. Mahmud E, Dauerman HL, Welt FGP, et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol. 2020. PMID: 32330544. doi:10.1016/j.jacc.2020.04.039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。